UF-Led Study Explores Differences in COVID-19 Severity Internationally
The U.S. Centers for Disease Control and Prevention recently awarded a $10 million grant to a team led by Rhoel Dinglasan to test why are some countries in the grip of COVID-19 while others appear less affected.
UF Team Identifies Novel Targets for COVID-19 Antivirals
A multidisciplinary team of researchers at the University of Florida is making progress in their search for targets that could be used for developing treatments for infections with COVID-19. The team posted a paper to bioRxiv reporting the identification of 53 novel genes and pathways that could become druggable targets for antiviral therapies for COVID-19 plus a broad array of coronavirus types.
Inventors Honored at Virtual Standing InnOvation Event
More than 200 innovators participated in a live-stream event and virtual happy hour to celebrate their achievements in fiscal year 2020. The... Read More
Harnessing Genome Editing for COVID-19 Drug Discovery
A University of Florida research team is harnessing the power of genomic editing to illuminate druggable targets in human cells for the... Read More
Expert: Outbreak Transmission Dynamics
As the world grapples for answers and action on the new coronavirus outbreak, researchers who study the dynamics of infectious disease outbreaks... Read More